Lee Susannah K, Jeakins Gabriella S, Tukiainen Aleksi, Hewage Emil, Armitage Oliver E
BIOS Health Ltd., Cambridge, United Kingdom.
Bioelectricity. 2020 Dec 1;2(4):321-327. doi: 10.1089/bioe.2020.0044. Epub 2020 Dec 16.
Bioelectric medicine leverages natural signaling pathways in the nervous system to counteract organ dysfunction. This novel approach has potential to address conditions with unmet needs, including heart failure, hypertension, inflammation, arthritis, asthma, Alzheimer's disease, and diabetes. Neural therapies, which target the brain, spinal cord, or peripheral nerves, are already being applied to conditions such as epilepsy, Parkinson's, and chronic pain. While today's therapies have made exciting advancements, their open-loop design-where stimulation is administered without collecting feedback-means that results can be variable and devices do not work for everyone. Stimulation effects are sensitive to changes in neural tissue, nerve excitability, patient position, and more. Closing the loop by providing neural or non-neural biomarkers to the system can guide therapy by providing additional insights into stimulation effects and overall patient condition. Devices currently on the market use recorded biomarkers to close the loop and improve therapy. The future of bioelectric medicine is more holistically personalized. Collected data will be used for increasingly precise application of neural stimulations to achieve therapeutic effects. To achieve this future, advances are needed in device design, implanted and computational technologies, and scientific/medical interpretation of neural activity. Research and commercial devices are enabling the development of multiple levels of responsiveness to neural, physiological, and environmental changes. This includes developing suitable implanted technologies for high bandwidth brain/machine interfaces and addressing the challenge of neural or state biomarker decoding. Consistent progress is being made in these challenges toward the long-term vision of automatically and holistically personalized care for chronic health conditions.
生物电医学利用神经系统中的自然信号通路来对抗器官功能障碍。这种新方法有潜力解决尚未满足需求的病症,包括心力衰竭、高血压、炎症、关节炎、哮喘、阿尔茨海默病和糖尿病。针对大脑、脊髓或周围神经的神经疗法已被应用于癫痫、帕金森病和慢性疼痛等病症。虽然当今的疗法取得了令人兴奋的进展,但其开环设计(即给予刺激时不收集反馈)意味着结果可能因人而异,而且设备并非对所有人都有效。刺激效果对神经组织变化、神经兴奋性、患者体位等因素敏感。通过向系统提供神经或非神经生物标志物来闭环,可以通过提供有关刺激效果和患者整体状况的更多见解来指导治疗。目前市场上的设备使用记录的生物标志物来闭环并改善治疗。生物电医学的未来将更加全面地实现个性化。收集到的数据将用于越来越精确地应用神经刺激以达到治疗效果。为实现这一未来,需要在设备设计、植入和计算技术以及神经活动的科学/医学解读方面取得进展。研究和商业设备正在推动对神经、生理和环境变化实现多层次的响应能力发展。这包括开发适用于高带宽脑机接口的合适植入技术以及应对神经或状态生物标志物解码的挑战。在应对这些挑战方面正不断取得进展,朝着为慢性健康状况提供自动且全面个性化护理的长期愿景迈进。